Pain management in multiple myeloma
- PMID: 20214522
- DOI: 10.1586/era.10.5
Pain management in multiple myeloma
Abstract
Pain is a prominent feature of multiple myeloma (MM) and may be caused by different underlying causes and mechanisms. Indeed, pain may be due to disease-related complications, iatrogenic causes or may be associated with other unrelated medical conditions. This symptom may be particularly devastating and can negatively affect the quality of life of the afflicted patients and their functional status. For most MM patients suffering from continuous nociceptive pain, the WHO's three-step analgesic ladder can provide adequate relief with oral options, although the high prevalence in MM patients of difficult-to-treat pains, such as pains due to skeletal mechanical instability or sustained by neuropathic mechanisms, makes the treatment approach a challenging concern. The management of pain in this setting requires a multidisciplinary approach integrating analgesics and causal interventions. This review focuses on the most common syndromes afflicting MM patients, attempting to provide an understanding of the underlying pain mechanisms and a discussion of the most commonly used treatment strategies.
Similar articles
-
[Physiopathology and management of pain in multiple myeloma].Minerva Med. 2010 Dec;101(6):427-38. Minerva Med. 2010. PMID: 21196902 Review. Italian.
-
Pain in malignant hematology.Expert Rev Hematol. 2011 Feb;4(1):81-93. doi: 10.1586/ehm.10.79. Expert Rev Hematol. 2011. PMID: 21322781 Review.
-
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
-
Efficacy of the world health organization analgesic ladder to treat pain in end-stage renal disease.J Am Soc Nephrol. 2006 Nov;17(11):3198-203. doi: 10.1681/ASN.2006050477. Epub 2006 Sep 20. J Am Soc Nephrol. 2006. PMID: 16988057 Clinical Trial.
-
Pain therapy.Crit Rev Oncol Hematol. 2009 May;70(2):145-59. doi: 10.1016/j.critrevonc.2008.12.005. Epub 2009 Feb 1. Crit Rev Oncol Hematol. 2009. PMID: 19188080
Cited by
-
Early integration of palliative care for patients with haematological malignancies.Br J Haematol. 2022 Oct;199(1):14-30. doi: 10.1111/bjh.18286. Epub 2022 Jun 7. Br J Haematol. 2022. PMID: 35670630 Free PMC article. Review.
-
Adherence to the evidence-based recommendations in managing bone health, pain, and mobility of patients with multiple myeloma: a mixed method in the Palestinian healthcare system.BMC Cancer. 2024 Mar 5;24(1):301. doi: 10.1186/s12885-024-12024-z. BMC Cancer. 2024. PMID: 38443861 Free PMC article.
-
Pain Management in Multiple Myeloma Patients: A Literature Review.Cureus. 2024 Mar 11;16(3):e55975. doi: 10.7759/cureus.55975. eCollection 2024 Mar. Cureus. 2024. PMID: 38601412 Free PMC article. Review.
-
Towards a better understanding of the relationship between side effects of analgesia and quality of life in patients with multiple myeloma.Support Care Cancer. 2016 Jan;24(1):9-10. doi: 10.1007/s00520-015-2868-5. Epub 2015 Aug 4. Support Care Cancer. 2016. PMID: 26238628 No abstract available.
-
An mHealth Pain Coping Skills Training Intervention for Hematopoietic Stem Cell Transplantation Patients: Development and Pilot Randomized Controlled Trial.JMIR Mhealth Uhealth. 2018 Mar 19;6(3):e66. doi: 10.2196/mhealth.8565. JMIR Mhealth Uhealth. 2018. PMID: 29555620 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical